North Run Capital’s MaxCyte MXCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$2.47M	Sell	451,960 -105,000	-19%	-$573K	5.67%	6
2022 Q3	$3.62M	Sell	556,960 -82,000	-13%	-$533K	7.35%	6
2022 Q2	$3.02M	Buy	638,960 +158,060	+33%	+$748K	6.2%	7
2022 Q1	$3.36M	Buy	+480,900	New	+$3.36M	4.94%	8